Immunservice Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 1
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 6

Immunservice General Information

Description

Developer of immune hormones intended to be used for the treatment of cancers, viral diseases and allergies. The company's hormones are natural biomimetic interleukin-2 drugs, which prevents patients with lung tumors from suffocating, rejuvenates the immune system and eliminates papillomavirus tumors, enabling healthcare professionals to deliver faster relief and effective outcomes for the target patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Christoph-Probst-Weg 4
  • 20251 Hamburg
  • Germany
+49 040 00000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunservice Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 05-Dec-2019 Completed Generating Revenue
3. Later Stage VC (Series C) 18-Feb-2015 Completed Generating Revenue
2. Later Stage VC 28-Jun-2014 Completed Startup
1. Seed Round 21-Jan-2008 Completed Startup
To view Immunservice’s complete valuation and funding history, request access »

Immunservice Executive Team (5)

Name Title Board Seat Contact Info
Conny Cloppenburg Chief Financial Officer
Edith Huland Ph.D Founder & Managing Director
To view Immunservice’s complete executive team members history, request access »

Immunservice Board Members (9)

Name Representing Role Since
Duncan McLaren MD Self Board Member 000 0000
Gerhard Uhlenbruck Ph.D Self Board Member 000 0000
Guido Sauter Ph.D Self Board Member 000 0000
Hans Heinzer Ph.D Self Board Member 000 0000
Hartwig Huland Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Immunservice Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunservice Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BPO Capital (Hamburg) Venture Capital Minority 000 0000 000000 0
Michael Otto Angel (individual) Minority 000 0000 000000 0
Hartwig Huland Angel (individual) Minority 000 0000 000000 0
Helmut Ponath Angel (individual) Minority 000 0000 000000 0
Hubertus Wald Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »